AIMIT Tech Reviewabout 3 hours ago
AI accelerates biologic drug design
8 min read
AI is speeding up biologic drug development by computationally generating and prioritizing candidate molecules. AstraZeneca uses a build-measure-learn loop where AI predicts which designs are most likely to succeed, focusing lab resources on top candidates. McKinsey estimates generative AI could cut drug discovery timelines by 50%.
Level
Hype check
Tap to vote and see what everyone thinks.
Summary by ByteBrief
